. . . . . . . "[Canakinumab (Ilaris�), an anti-interleukin-1? monoclonal antibody, is a novel approach to treat acute gouty arthritis flares in a targeted population of patients in whom treatment options are limited.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:44+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .